After multivariable adjustment for potential confounders in patient and tumor characteristics in Cox regression models, Lu-PSMA was also independently associated with better PFS, relative to ARPI treatment (HR: 0.24, p = 0.045, Table 2A). Here, FOLH1 is linked to neoplasm.